<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(2)</volume><submitter>Mercadante V</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>This systematic review aimed to assess the updated literature for the prevention of salivary gland hypofunction and xerostomia induced by non-surgical cancer therapies.&lt;h4>Methods&lt;/h4>Electronic databases of MEDLINE/PubMed, EMBASE, and Cochrane Library were searched for randomized controlled trials (RCT) that investigated interventions to prevent salivary gland hypofunction and/or xerostomia. Literature search began from the 2010 systematic review publications from the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) up to February 2024. Two independent reviewers extracted information regarding study design, study population, cancer treatment modality, interventions, outcome measures, methods, results, risk of bias (</pubmed_abstract><journal>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</journal><pagination>87</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11723892</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A systematic review of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies: prevention strategies.</pubmed_title><pmcid>PMC11723892</pmcid><pubmed_authors>Mercadante V</pubmed_authors><pubmed_authors>Clark H</pubmed_authors><pubmed_authors>Napenas JJ</pubmed_authors><pubmed_authors>Elad S</pubmed_authors><pubmed_authors>Kurup S</pubmed_authors><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Andabak-Rogulj A</pubmed_authors><pubmed_authors>Saunders DP</pubmed_authors><pubmed_authors>Peterson DE</pubmed_authors><pubmed_authors>Abdalla-Aslan R</pubmed_authors><pubmed_authors>Jaguar GC</pubmed_authors><pubmed_authors>Vissink A</pubmed_authors><pubmed_authors>Hovan A</pubmed_authors><pubmed_authors>Van Leeuwen S</pubmed_authors><pubmed_authors>Smith DK</pubmed_authors><pubmed_authors>Jensen SB</pubmed_authors><pubmed_authors>Brennan MT</pubmed_authors><pubmed_authors>Gueiros LA</pubmed_authors><pubmed_authors>Lynggaard CD</pubmed_authors><pubmed_authors>Fregnani ER</pubmed_authors><pubmed_authors>Laheij AMGA</pubmed_authors></additional><is_claimable>false</is_claimable><name>A systematic review of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies: prevention strategies.</name><description>&lt;h4>Purpose&lt;/h4>This systematic review aimed to assess the updated literature for the prevention of salivary gland hypofunction and xerostomia induced by non-surgical cancer therapies.&lt;h4>Methods&lt;/h4>Electronic databases of MEDLINE/PubMed, EMBASE, and Cochrane Library were searched for randomized controlled trials (RCT) that investigated interventions to prevent salivary gland hypofunction and/or xerostomia. Literature search began from the 2010 systematic review publications from the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) up to February 2024. Two independent reviewers extracted information regarding study design, study population, cancer treatment modality, interventions, outcome measures, methods, results, risk of bias (</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-02T07:15:24.068Z</modification><creation>2025-04-07T05:01:52.883Z</creation></dates><accession>S-EPMC11723892</accession><cross_references><pubmed>39792256</pubmed><doi>10.1007/s00520-024-09113-x</doi></cross_references></HashMap>